Global Immunoassay Instruments Market: by Types, End-User, Regional Analysis and Forecast 2020

Transparency Market Research Report Added “ AImmunoassay Instruments Market

(Product Chemiluminescence (CLI), Immunofluorescence (IFA) & Radioimmunoassay (RIA) Analyzers, Enzyme Linked Fluorescence (ELFA) & Multiplexed Assay Systems, Enzyme Immunoassay Instruments Application Oncology, Endocrinology, Infectious Diseases, Therapeutic Drug Monitoring, Cardiology, Autoimmune Disorders & Drugs of Abuse) " to its database.

Immunoassay Instruments Market: Discription Immunoassay is a laboratory-based diagnostic procedure performed using an immunological

reaction

of

antibodies.

Immunoassay

instruments

measure

the

formation of antibody-antigen complexes in blood samples or other body fluids and are commonly

employed

to

detect

analytes

in

qualitative

(positive/negative)

or

quantitative manner. An example of qualitative analysis of immunoassay test include immunoassay test for pregnancy by detecting human chorionic gonadotropin (hCG) in urine samples. Immunoassay tests now-a-days are exploring new avenues of applications in diagnosing infectious diseases, toxicology testing, detection of cancer biomarkers and other drug monitoring tests. Immunoassay techniques are especially suited for analyzing compounds that are present in extremely low concentration (nanogram to picogram) and without any prior treatments to enhance its detection.

Several common technologies that are employed by immunoassays include enzymelinked

immunosorbent

assay

(ELISA),

immunofluorescence,

radioimmunoassay,

chemiluminescent immunoassay, enzyme linked fluorescence and other similar techniques. Global immunoassay instruments market is analyzed on the basis of products and application. The product market is sub-segmented into six major categories namely Chemiluminescence (CLI) Analyzers, Immuno Fluorescence (IFA) Analyzers, Enzyme Immunoassay Instruments, Radioimmunoassay (RIA) Analyzers, Enzyme Linked Fluorescence (ELFA) Analyzers and Multiplexed Assay Systems.

Browse Market Research Report: http://www.transparencymarketresearch.com/immunoassay-instruments-market.html Immunoassay Instruments Market: Overview Immunoassay instruments market is witnessing a rapid technological growth that has resulted in significant market opportunity for efficient bioanalytical platforms.

Currently, market players are engaged in developing immunoassay platforms with enhanced capabilities such as broad menu of tests, higher sensitivity and specificity.

Other major advances introduced to researchers include shorter turnaround times (TAT), higher productivity and easy operation thereby ensuring efficient detection and determination with accurate results. The market is witnessing significant advances in the design of immunoassay platforms shifting from conventional non-competitive assays to competitive assays that are permitting the efficient detection of small molecules such as drug pollutants and metabolites. For instance, introduction of ADVIA Centaur CP Immunoassay System by Siemens Healthcare, a mid-sized immunoassay system that provides a broad menu of tests and enhanced workflow which enables overall cost reduction and eliminate the need for multiple systems.

Although, the use of immunoassay platforms has been confined to hospitals and reference laboratories, currently, there is an increasing preference for commercial diagnostic laboratories owing to their special care and short turnaround times as compared to hospitals. Tier-1 diagnostic laboratories are currently focusing on expanding their operations in less developed areas by acquiring Tier - 2 and Tier – 3 laboratories with minimal infrastructure. This creates a strong demand for compact and portable assay platforms with high reliability and sensitivity. In addition, these platforms can run on batteries in case of power failure and can be moved in ambulances in case of emergency requirements. All these features along with high affordability are expected to provide impressive growth opportunities for immunoassay instruments market.

Fill the form for an exclusive sample of this report: http://www.transparencymarketresearch.com/sample/sample.php? flag=B&rep_id=1635

Table of Contents Chapter 1 Introduction 1.1 Report Description 1.2 Research Methodology 1.2.1 Sources 1.2.1.1 Secondary Research

1.2.1.2 Primary Research 1.2.1.3 Assumptions 1.3 Market Segmentation 1.4 List of Abbreviations Chapter 2 Executive Summary 2.1 Comparative Analysis: Global Immunoassay Instruments Market, by Geography, 2013 & 2020 (Value %) Chapter 3 Market Overview 3.1 Introduction 3.1.1 Flow Chart of Immunoassay Development, Optimization and Validation 3.2 Market Potential of Immunoassay Instruments 3.2.1 Biomarker Discovery Process 3.3 Future Scenario of Immunoassay Instruments Market 3.4 Event Impact Analysis 3.5 Market Dynamics 3.6 Market Drivers 3.6.1 Rising incidence of chronic infectious diseases will drive the immunoassay instruments market 3.6.2 Rate of HIV Infections by World Regions, (2001-2012) 3.6.3 Technological advances coupled with enhanced discovery of specific biomarkers will drive the demand for immunoassay instruments 3.6.4 Increasing preference for personalized medicine creates a demand for novel and specific immunoassays 3.7 Market Restraints 3.7.1 High cost associated with technologically advanced immunoassay systems 3.8 Market Opportunities

3.8.1 Focus on developing compact, portable reliable immunoassay instruments 3.8.2 Investments in emerging economies 3.9 Value Chain Analysis: Global Immunoassay Instruments Market 3.10 Regulatory and Reimbursement Overview 3.11 Porter’s Five Forces Analysis for the Global Immunoassay Instruments Market 3.11.1 Bargaining power of suppliers 3.11.2 Bargaining power of buyers 3.11.3 Threat of substitutes 3.11.4 Threat of new entrants 3.11.5 Competitive rivalry 3.12 Market Attractiveness Analysis: Global Immunoassay Instruments Market, by Geography 3.13 Comparative Analysis: Global Immunoassay Instruments Market, by End Users, 2013 & 2020 (Value %) 3.14 Competitive Landscape 3.14.1 Global Immunoassay Instruments Market Share by Key Players, 2013 (Value %) Chapter 4 Global Immunoassay Instruments Market, by Products 4.1 Overview 4.1.1 Global Immunoassay Instruments Market Revenue, by Products, 2012 - 2020 (USD Billion) 4.2 Comparative Analysis: Global Immunoassay Instruments Market, by Products, 2013 & 2020 (Value %) 4.3 Chemiluminescence (CLI) Analyzers 4.3.1 Global Chemiluminescence (CLI) Analyzers Market Revenue, 2012- 2020 (USD Billion) 4.4 Immunofluorescence Analyzers (IFA)

4.4.1 Global Immunofluorescence Analyzers Market Revenue, 2012- 2020 (USD Billion) 4.5 Enzyme Immunoassay Instruments 4.5.1 Global Enzyme Immunoassay (EIA) Instruments Market Revenue, 2012 - 2020 (USD Billion) 4.6 Radioimmunoassay (RIA) Instruments 4.6.1 Global Radioimmunoassay (RIA) Instruments Market Revenue, 2012 – 2020 (USD Billion) 4.7 Enzyme Linked Fluorescent Assay (ELFA) Systems 4.7.1 Global Enzyme Linked Fluorescent Assays (ELFA) Instruments Market Revenue, 2012 – 2020 (USD Billion) 4.8 Multiplexed Assay Systems 4.8.1 Global Multiplexed Assay Systems Market Revenue, 2012 – 2020 (USD Billion) Chapter 5 Global Immunoassay Instruments Market, by Application 5.1 Overview 5.1.1 Global Immunoassay Instruments Market Revenue, by Application, 2012 – 2020 (USD Billion) 5.2 Comparative Analysis: Global Immunoassay Instruments Market, by Application, 2012 – 2020 (Value %) 5.3 Endocrinology 5.3.1 Global Endocrinology Application Market Revenue, 2012- 2020 (USD Billion) 5.4 Infectious Disease Testing 5.4.1 Global Infectious Disease Testing Application Market Revenue, 2012- 2020 (USD Billion) 5.5 Oncology 5.5.1 Global Oncology Application Market Revenue, 2012- 2020 (USD Billion) 5.6 Cardiology 5.6.1 Global Cardiology Application Market Revenue, 2012- 2020 (USD Billion)

5.7 Therapeutic Drug Monitoring 5.7.1 Global Therapeutic Drug Monitoring Application Market Revenue, 2012- 2020 (USD Billion) 5.8 Autoimmune Diseases Testing 5.8.1 Global Autoimmune Diseases Testing Application Market Revenue, 20122020 (USD Billion) 5.9 Drugs of Abuse Testing 5.9.1 Global Drug Abuse Testing Application Market Revenue, 2012- 2020 (USD Billion) Chapter 6 Global Immunoassay Instruments Market, by Geography 6.1 Overview 6.1.1 Global Immunoassay Instruments Market Revenue, by Geography, 2012 – 2020 (USD Billion) 6.2 North America 6.2.1 North America Immunoassay Instruments Market Revenue, 2012 – 2020 (USD Billion) 6.3 Europe 6.3.1 Europe Immunoassay Instruments Market Revenue, 2012 – 2020 (USD Billion) 6.4 Asia-Pacific 6.4.1 Asia-Pacific Immunoassay Instruments Market Revenue, 2012 – 2020 (USD Billion) 6.5 Rest of the World (RoW) 6.5.1 RoW Immunoassay Instruments Market Revenue, 2012 – 2020 (USD Billion) Chapter 7 Recommendations 7.1 Recommendations 7.1.1 Enhancing distribution networks 7.1.2 Improvements in after sale services to hospitals, diagnostic labs and private practitioners

7.1.3 Expansion in emerging regions such as Asia and Africa Chapter 8 Company Profiles 8.1 Abbott Laboratories 8.1.1 Company Overview 8.1.2 Financial Overview 8.1.3 Product Portfolio 8.1.4 Business Strategies 8.1.5 Recent Developments 8.2 Beckman Coulter, Inc. 8.2.1 Company Overview 8.2.2 Financial Overview 8.2.3 Product Portfolio 8.2.4 Business Strategies 8.2.5 Recent Developments 8.3 bioMerieux, Inc. 8.3.1 Company Overview 8.3.2 Financial Overview 8.3.3 Product Portfolio 8.3.4 Business Strategies 8.3.5 Recent Developments 8.4 DiaSorin S.p.A 8.4.1 Company Overview 8.4.2 Financial Overview 8.4.3 Product Portfolio

8.4.4 Business Strategies 8.4.5 Recent Developments 8.5 F. Hoffman-La Roche, Ltd. 8.5.1 Company Overview 8.5.2 Financial Overview 8.5.3 Product Portfolio 8.5.4 Business Strategies 8.5.5 Recent Developments 8.6 Merck Millipore 8.6.1 Company Overview 8.6.2 Financial Overview 8.6.3 Product Portfolio 8.6.4 Business Strategies 8.6.5 Recent Developments 8.7 Ortho Clinical Diagnostics 8.7.1 Company Overview 8.7.2 Financial Overview 8.7.3 Product Portfolio 8.7.4 Business Strategies 8.7.5 Recent Developments 8.8 Siemens Healthcare 8.8.1 Company Overview 8.8.2 Financial Overview 8.8.3 Product Portfolio

8.8.4 Business Strategies 8.8.5 Recent Developments 8.9 Sysmex Corporation 8.9.1 Company Overview 8.9.2 Financial Overview 8.9.3 Product Portfolio 8.9.4 Business Strategies 8.9.5 Recent Developments 8.10 Thermo Fisher Scientific 8.10.1 Company Overview 8.10.2 Financial Overview 8.10.3 Product Portfolio 8.10.4 Business Strategies 8.10.5 Recent Developments List of Figures FIG. 1 Immunoassay Instruments Market Segmentation FIG. 2 Global Immunoassay Instruments Market, by Applications, 2013 (USD Billion) FIG. 3 Global Immunoassay Instruments Market, by Products, 2013 (USD Billion) FIG. 4 Comparative Analysis: Global Electrodes for Medical Devices Market, by Geography, 2013 & 2020 (Value %) FIG. 5 Immunoassay Development, Optimization and Validation Process FIG. 6 Biomarker Discovery Process FIG. 7 Rate of HIV Infections by World Regions, (2001 – 2012) FIG. 8 Global Immunoassay Instruments Market Value Chain Analysis FIG. 9 Porter’s Five Forces Analysis: Global Immunoassay Instruments Market

FIG. 10 Market Attractiveness Analysis: Global Immunoassay Instruments Market, by Geography, 2013 FIG. 11 Comparative Analysis: Global Immunoassay Instruments Market, by End Users, 2013 & 2020 (Value %) FIG. 12 Immunoassay Instruments: Global Market Share by Key Players, 2013 (Value %) FIG. 13 Comparative Analysis: Global Immunoassay Instruments Market, by Products, 2013 & 2020 (Value %) FIG. 14 Global Chemiluminescence (CLI) Analyzers Market Revenue, 2012 – 2020 (USD Billion) FIG. 15 Global Immunofluorescence Analyzers Market Revenue, 2012 – 2020 (USD Billion) FIG. 16 Global Enzyme Immunoassay (EIA) Instruments Market Revenue, 2012 - 2020 (USD Billion) FIG. 17 Global Radioimmunoassay (RIA) Instruments Market Revenue, 2012 – 2020 (USD Billion) FIG. 18 Global ELFA Instruments Market Revenue, 2012 – 2020 (USD Billion) FIG. 19 Global Multiplexed Assay Systems Market Revenue, 2012 – 2020 (USD Billion) FIG. 20 Comparative Analysis: Global Application, 2013 & 2020 (Value %)

Immunoassay

Instruments

Market,

by

FIG. 21 Global Endocrinology Application Market Revenue, 2012 – 2020 (USD Billion) FIG. 22 Global Infectious Disease Testing Application Market Revenue, 2012 – 2020 (USD Billion) FIG. 23 Global Oncology Application Market Revenue, 2012 – 2020 (USD Billion) FIG. 24 Global Cardiology Application Market Revenue, 2012 – 2020 (USD Billion) FIG. 25 Global Therapeutic Drug Monitoring Application Market Revenue, 2012 – 2020 (USD Billion) FIG. 26 Global Autoimmune Diseases Testing Application Market Revenue, 2012 – 2020 (USD Billion) FIG. 27 Global Drug Abuse Testing Application Market Revenue, 2012 – 2020 (USD Billion)

FIG. 28 North America Immunoassay Instruments Market Revenue, 2012 – 2020 (USD Billion) FIG. 29 Europe Immunoassay Instruments Market Revenue, 2012 – 2020 (USD Billion) FIG. 30 Asia-Pacific Immunoassay Instruments Market Revenue, 2012 – 2020 (USD Billion) FIG. 31 RoW Immunoassay Instruments Market Revenue, 2012 – 2020 (USD Billion) FIG. 32 Abbott Laboratories, Inc.: Annual Revenue, 2011 – 2013 (USD Million) FIG. 33 bioMerieux, Inc.: Annual Revenue, 2011 – 2013 (USD Million) FIG. 34 DiaSorin, Annual Revenue: 2011 – 2013 (USD Million) FIG. 35 F. Hoffman-La Roche, Ltd.: Annual Revenue (Group Sales), 2011 – 2013 (USD Million) FIG. 36 Merck Millipore, Annual Revenue, 2010 – 2012 (USD million) FIG. 37 Ortho Clinical Diagnostics, Annual Revenue: 2011 – 2013 (USD Million) FIG. 38 Siemens Healthcare, Annual Revenue (Group Revenue): 2011– 2013 (USD Million) FIG. 39 Sysmex Corporation, Annual Revenue, 2011 – 2013 (USD Million) FIG. 40 Thermo Fisher Scientific, Annual Revenue: 2011 – 2013 (USD million) List of Tables TABLE 1 List of Abbreviations TABLE 2 Market Snapshot: Global Immunoassay Instruments Market TABLE 3 Event Impact Analysis, 2012 – 2020 TABLE 4 Global Immunoassay Instruments Market Revenue, by Products, 2012 – 2020 (USD Billion) TABLE 5 Global Immunoassay Instruments Market Revenue, by Application, 2012 – 2020 (USD Billion) TABLE 6 Global Immunoassay Instruments Market Revenue, by Geography, 2012 – 2020 (USD Billion)

About Us Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We have an experienced team of Analysts, Researchers, and Consultants, who us e proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Each

TMR Syndicated Research report covers a different sector – such as

pharmaceuticals, chemical, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, our syndicated reports thrive to provide clients to serve their overall research requirement.

Contact Transparency Market Research 90 State Street, Suite 700 Albany, NY 12207 Tel: +1-518-618-1030 USA – Canada Toll Free: 866-552-3453 Email: sales@transparencymarketresearch.com Website: http://www.transparencymarketresearch.com Browse market research blog: https://tmrresearch.blogspot.com/